Are you attending #DDW2024? We'll be there, and we'd love to meet with you! Reach out to one of our analysts to arrange a time to chat. Edit Kovalcsik, PhD Vasilis Roumpelakis Tanuj Sircar Gaja Gasiorek Sumaira Malik
GlobalData Healthcare
Information Services
Predict the future to transform your business in the healthcare, medical devices & pharma industries.
About us
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value. Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services. Among other benefits, our informed industry perspectives help clients understand how to generate the maximum return from their key markets, identify opportunities from emerging trends, and devise strategies for growth with confidence.
- Website
-
https://www.globaldata.com/
External link for GlobalData Healthcare
- Industry
- Information Services
- Company size
- 1,001-5,000 employees
- Headquarters
- London
- Type
- Public Company
- Founded
- 2010
- Specialties
- Research and Consulting, Strategic Analysis, Competitive Benchmarking, Market Forecasting, Medical, Pharmaceutical, and Data Analysis
Locations
-
Primary
John Carpenter Street
London, GB
Employees at GlobalData Healthcare
-
Alan Raider
Life-science industry sales and BD professional
-
Kate Sandman
Enabling Decisions via Data, Analytic Tools and Critical Insights on BioPharma
-
Ron Cohen
Vice President; Strategic Partner to the Pharmaceutical Industry.
-
Valentina Gburcik
Senior Director at GlobalData Healthcare
Updates
-
If you missed Fiona Barry's talk on the State of the Biopharma Industry in 2024 at this year's Clinical Trial Supply Europe conference, drop us an email or message to see the slides! Fiona presented in Barcelona on the outlook for drugs, trials, and manufacturing. Clientservices@globaldata.com
-
🚀 Exciting growth ahead for the ovarian cancer market! 🌐 In 2022, it was valued at $3.3 billion across the 7MM (US, France, Germany, Italy, Spain, UK, Japan). 📈 With a CAGR of over 1%, we’re looking at significant advancements by 2032. https://lnkd.in/gT38nsGQ #Healthcare #OvarianCancer #MarketGrowth #ClinicalTrials #UnmetNeeds #GlobalHealth
-
🌍 The vaccine rush has reshaped the landscape for CROs in 2024! 🚀 From collaborative digital platforms to leveraging AI, we're witnessing unprecedented speed and flexibility in clinical trials. 💡 Discover how these trends, highlighted by GlobalData, are shaping the future of infectious disease research. https://lnkd.in/d64se_Ff Merative Zelta by Merative #CRO #HealthcareInnovation #PharmaIndustry #HealthTech #Vaccine #Infectiousdiseases
Infectious disease trends for CROs in 2024
pharmaceutical-technology.com
-
Tired of receiving hundreds of #news alerts? Access all the business insights you need in one place with #DECODED #Healthcare. 🌍 Make news easier, subscribe now:
Newsletter subscription - GlobalData
globaldata.com
-
🌟 Exciting news in the realm of dyslipidemia treatment! 🚀 Arrowhead Pharmaceuticals' plozarsiran, now known as ARO-APOC3, has shown remarkable potential in the Phase II SHASTA-2 trial. 📈 Final data reveals an astounding reduction in APOC3 and triglycerides by up to 86% and 90%, respectively. If approved, plozasiran could be a game-changer in addressing critical unmet needs in dyslipidemia management, according to GlobalData. 👩⚕️ Dr. Shireen Mohammad, PhD Cardiovascular & Metabolic Disorders Analyst at GlobalData, emphasizes the urgency of this breakthrough: "There is a critical unmet need for new FCS treatments plozasiran addresses the significant unmet need in the treatment of dyslipidemia." 💊 Patients with SHTG face limited treatment options, making plozasiran's potential even more impactful. https://lnkd.in/dk7Kz6_c #pharma #healthcare #DyslipidemiaTreatment #MedicalBreakthrough
Arrowhead Pharmaceuticals plozarsiran holds potential to treat dyslipidemia, says GlobalData
globaldata.com
-
GlobalData Healthcare reposted this
📢 Yesterday marked the start of Women’s Health Week. 🩺 Women’s healthcare is persistently overlooked, neglected, and underfunded, and many women face difficulties accessing quality care. 💡 But with a wide range of technologies and products available to address health issues, Femtech has the potential to change women’s healthcare for the better. Check out our latest FemTech report 👇 For Disruptor clients 👉 https://lnkd.in/e8YBVkBV For everyone else 👉 https://lnkd.in/eDSXrWsV #FemTech #WomensHealth #WomensHealthWeek
-
🏥 Dive into the future of healthcare with our latest report on Augmented Reality (AR) adoption in the industry! Despite its potential, AR faces barriers in understanding and use cases, unlike its counterpart VR. However, it's making strides in supporting healthcare providers, especially in surgical assistance and training. Discover how pharmaceutical and medical device companies are leveraging AR in niche applications across manufacturing, sales, and marketing. https://lnkd.in/duq7a8m6 #pharma #VR #AR #medicaldevices #HealthcareInnovation #AugmentedReality
Augmented Reality (AR) in Healthcare - Thematic Research
globaldata.com
-
📊 Excited to announce our latest report: 'Regulated mHealth Apps! 📱 Discover key trends shaping the mobile health landscape over the next 12-24 months. 🚀 Gain insights into the growth trajectory, core components, and major players in the mHealth theme. 💡 Unlock valuable company scorecards to predict tomorrow's leaders. https://lnkd.in/g25t4996 #mHealth #Healthcare #Innovation #Tech #mHealth #FutureHealth
Regulated mHealth Apps - Thematic Intelligence
globaldata.com
-
🔍 Dive into our latest report on the Coronary Stents Market! 📊 Valued at $4.37 billion in 2023, this dynamic market is projected to grow at a CAGR of less than 1% till 2033. With lifestyles evolving and diets shifting towards the unhealthy, coronary heart disease risks are on the rise, fueling market expansion. https://lnkd.in/gcvQDvPY #CoronaryStents #MarketInsights #Healthcare #Innovation